1. Predicting Alzheimer’s years in advance
A Swedish study conducted in 2012 brought to light the successful use of biomarkers – placed in the cerebrospinal fluid of patients who may be susceptible to developing Alzheimer’s or dementia. These biomarkers were shown to typically undergo characteristic changes 5-10 years before the onset of Alzheimer’s, indicating a discovery with promising implications for the earlier detection of the disease.
2. High cholesterol increases the risk of Alzheimer’s
There is a distinct link between sufferers of Down Syndrome and those with Alzheimer’s – with both conditions resulting from a defect in chromosome 21, making those with Down Syndrome a valuable source of study for Alzheimer’s. Researches have thus found that high levels of cholesterol have been found to disrupt the composition of chromosome 21, leading to the development of Alzheimer’s disease.
3. Extra Virgin Olive oil known to protect against Alzheimer’s
A 2013 study has brought to light that a substance known as oleocanthal, found in Extra Virgin Olive oil, helps to boost the brain’s production of key proteins and enzymes – reducing the risk of developing Alzheimer’s disease. The study also went on the show that the prevalence of Alzheimer’s is drastically lower in Mediterranean countries versus the rest of the world.
4. Controlling your hypertension may keep Alzheimer’s at bay
High levels of amyloid levels in the human body have been proven to result in the development of Alzheimer’s disease over time. Those that are already pre-disposed to contracting the disease can be at higher risk of developing Alzheimer’s if their hypertension is not controlled – leading to higher levels of amyloid. Make sure to visit your health practitioner and get your blood pressure in check!
5. New medication helps to improve the memory of moderate Alzheimer’s
Clinical trials have been conducted on the medication known as ORM-12741, where it is said this medication will improve the memory-related problems associated with moderate to severe Alzheimer’s. A three-month clinical trial was conducted in the United States where patients who consumed the drug scored higher on memory tests than those that received a placebo medication!
The research environment surrounding Alzheimer’s and dementia is an ever growing and inspired one, helping to continually install hope in family members, carers and sufferers themselves. When a loved-one is diagnosed with Alzheimer’s or dementia, it does not signal the ‘end’ for them, and with daily research and significant discoveries in the diagnosis and treatment field, our loved ones can live an equally fulfilled life with a better understanding and knowledge of Alzheimer’s disease.